English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

It is an honor to have been selected to serve as the editor-inchief of Hormones and Cancer, the newest of the Endocrine Society journals (published jointly by the Endocrine Society and Springer). I admire and commend the founding editor-inchief, Dr. Jonathan Li, and the second (and immediate past) editor-in-chief, Dr. Carol A. Lange, for their accomplishments in establishing and further developing this relatively new journal. I have served on the Editorial Board since its inception, and it has been a pleasure to see the progress the journal has made from a good idea to a promising journal with increasing submissions and impact. One of the successes during Dr. Lange’s tenure was in recruiting experts in androgen receptor splice variants in prostate cancer and experts in thyroid cancer to write two series of excellent and timely reviews on these topics. The journal is now indexed in PubMed and will soon receive its first Impact Factor. My immediate goal is to increase the visibility and impact of the journal in basic, translational, and clinical studies of hormone-dependent cancers and cancers of endocrine organs that produce hormones. This includes appointing editors and editorial board members with established expertise in the areas covered by the journal, modifications of the journal web sites, additional types of journal content, and increased advertising. My ultimate goal is to develop the journal so that it is one of the first choices of authors for submission of studies in these topics. The annual meeting of the Endocrine Society routinely includes these topics as major areas of interest for symposia, oral sessions, and poster sessions, but papers on these topics have not previously had a specific Endocrine Society journal home. Hormones and Cancer is a novel multidisciplinary journal that covers all aspects of the intersection of endocrinology and cancer. This includes studies of endocrine neoplasias and hormone action in any cancer. Hormones and Cancer is a unique journal for the Endocrine Society in that its articles range from basic science through translational studies to clinical studies and trials. Thus, it addresses the interests of all three Endocrine Society constituencies, basic scientists, clinician scientists, and clinicians in practice. This is an exciting, but challenging time for all of our constituencies. The rapid development of new technologies provides exciting new opportunities in all areas of study and encourages studies across diverse fields of expertise. Bioinformatics approaches and available databases facilitate studies that span the gamut from basic research to clinical studies. Investigators can quickly determine whether changes observed in vitro or in pre-clinical models are also observed in clinical specimens. Scientists and clinicians alike are facing many challenges with reduced support and funding from NIH and other sources. The publishing industry also has undergone many changes and will continue to change as various forms of electronic publishing increase the types of content (for example, videos) that can be produced and journals alter their access options. With the proliferation of journals including many new online journals not associated either with scientific societies or with established scientific publishers, authors have a bewildering variety of choices for publication. Moreover, there is increasing reliance on PubMed and Google and on key words to identify articles of interest rather than through perusal of tables of contents of a subset of journals. There are a number of benefits to publishing in Hormones and Cancer. The journal offers rapid peer review by experts in the field with clear critiques defining what is needed for publication. Because this is a combined Springer/Endocrine Society * Nancy L. Weigel nweigel@bcm.edu

Hormones and Cancer: an Exciting Young Journal for an Expanding Field of Basic, Translational, and Clinical Study